当前位置:Public Access >页面
Chinese/English
A study of PD-1/PD-L1 inhibitors combined with Lenvatinib for advanced unresectable liver cancer as the neoadjuvant therapy
Filter Options
Patient No. Patient Name Patient Gender
Sitting Education Date of enrollment FromTo
       More Options
Patient No Gender Date of enrollment Sitting Creater Operate
1-141 Man 2021-12-23 xujping
1-185 Man 2021-12-17 xujping
1-191 Man 2021-12-17 xujping
1-190 Man 2021-12-17 xujping
1-189 Man 2021-12-17 xujping
1-188 Man 2021-12-17 xujping
1-161 Man 2021-10-22 xujping
1-186 Woman 2021-10-08 xujping
1-184 Man 2021-10-08 xujping
1-183 Man 2021-10-08 xujping
1-182 Man 2021-10-08 xujping
1-181 Man 2021-10-08 xujping
1-178 Man 2021-10-08 xujping
1-176 Man 2021-10-08 xujping
1-174 Woman 2021-10-08 xujping
1-173 Man 2021-10-08 xujping
1-170 Man 2021-09-30 xujping
1-169 Man 2021-09-30 xujping
1-162 Man 2021-09-30 xujping
1-132 Man 2021-08-26 xujping
1-135 Woman 2021-08-24 xujping
1-171 Man 2021-05-16 xujping
1-168 Man 2021-07-30 xujping
1-165 Man 2021-07-30 xujping
1-164 Man 2021-07-30 xujping